Cost-effectiveness of omalizumab in real world uncontrolled allergic asthma patients
Objective To estimate the cost-effectiveness of omalizumab compared with standard of care in the treatment and control of severe persistent asthma, using the outcomes from the Portuguese subpopulation of the eXpeRience registry.Methods This was a pragmatic cost-effectiveness analysis based on real w...
Saved in:
| Main Authors: | A. Arrobas, M.P. Barbosa, S. Rabiais, B. Vandewalle, J. Félix |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis
2021-03-01
|
| Series: | Pulmonology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1016/j.pulmoe.2020.03.001 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Pharmaco-Economic Analyzis of Treating Severe Uncontrolled Child Asthma with Omalizumab — Actual Russian Clinical Practice Data
by: A. S. Kolbin, et al.
Published: (2016-11-01) -
Real-world clinical utility (effectiveness) of omalizumab as add-on therapy in patient with difficult-to-treat severe allergic asthma
by: Rowshne Jahan, et al.
Published: (2025-01-01) -
Effectiveness and pharmacoeconomic analysis of the treatment of severe asthma with omalizumab in clinical practice
by: Eva Martínez-Moragón, et al.
Published: (2019-05-01) -
Comparative Analysis of ICS Combined with LABA versus Addition of Omalizumab on Transcriptomic Expression Profiles in Patients with Allergic Asthma
by: Liang YR, et al.
Published: (2025-06-01) -
Drug survival of omalizumab in atopic asthma: Impact of clinical and genetic variables
by: Susana Rojo-Tolosa, et al.
Published: (2025-12-01)